References
Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 2010; 34: 405–17.
Katsoulas N, Chrysomali E, Piperi E, Levidou G, Sklavounou-Andrikopoulou A. Atypical methotrexate ulcerative stomatitis with features of lymphoproliferative like disorder: report of a rare ciprofloxacin-induced case and review of the literature. J Clin Exp Dent 2016; 8: e629–33.
Deeming GMJ, Collingwood J, Pemberton MN. Methotrexate and oral ulceration. Br Dent J 2005; 198: 83–5.
Satou A, Banno S, Hanamura I, et al. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: single center series of nine cases: MTX-associated EBVMCU. Pathol Int 2019; 69: 21–8.
Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004; 50: 1740–51.
Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011; 117: 4726–35.
Nakauyaca A, Kalro A, Donaldson E, Patel H. Fatal outcome of an Epstein-Barr virus positive mucocutaneous ulcer secondary to methotrexat. e. Intern Med J 2016; 46: 1226–8.
Li DTS, Lo AWI, Su Y-X. Oral Epstein-Barr virus-positive mucocutaneous ulcer: gingival presentation of a benign lymphoproliferative lesion. Int J Oral Maxillofac Surg 2020; 49: 1351–4.
Ikeda T, Gion Y, Sakamoto M, et al. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer. Mod Pathol 2020; 33: 2437–48.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure. Financial support: none. Conflicts of interest: none.
About this article
Cite this article
Donzel, M., Neyrand, S., Skowron, F. et al. An EBV-positive mucocutaneous ulcer in an unusual location with a surprising evolution. Eur J Dermatol 31, 121–125 (2021). https://doi.org/10.1684/ejd.2021.3982
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2021.3982